Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

PepGen's oligo succeeds in Phase 2; Ionis' and ImmunityBio's stocks sag

Plus news about Coherus Oncology, JW Therapeutics and PsiThera. PepGen’s positive mid-stage results in DM1: PepGen said its oligonucleotide therapy PGN-EDODM1 showed positive early signals in a cohort of Phase 2 patients with myotonic dystrophy ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Finance & Markets

TLT: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares 20+ Year Treasury Bond ETF (Symbol: TLT) where we have…

More from Tuesday 10 November →